CoChat

Human T cell engineering via serial delivery of mRNA encapsulated within lipid nanoparticles

Open access
Ramamurthy, Apoorva, Scimonelli, Giulia, Murphy, William L., Saha, Krishanu · 2026 · Molecular Therapy Nucleic Acids

The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index; none of the 57 sources its claims cite is checked for support yet.

Abstract

Human T cells modified with nucleic acids constitute a powerful and emerging therapeutic modality for cancer, autoimmune disorders, and aging-related diseases. However, delivering nucleic acids, such as mRNA encoding synthetic receptors, transcription factors, cytokines, or genome editors to T cells can be challenging, as nucleic acids can unintentionally reduce viable T cell yield and function, particularly when delivered sequentially ex vivo . To address this challenge, we evaluated the efficiency of serial non-viral delivery of synthetic mRNA encapsulated within lipid nanoparticles (LNPs) incorporating cationic lipid, 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP), and fusogenic helper lipid, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE). DOTAP/DOPE-containing LNPs delivered mRNA more efficiently than a clinically benchmarked 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC)-containing LNP formulation, resulting in significantly higher protein expression in primary human T cells. Furthermore, DOTAP/DOPE-LNP delivery resulted in 100% higher yield of live cells compared to electroporation, an advantage that compounded over serial rounds, with LNP-treated cultures maintaining substantially more viable cells through all four transfections. Additionally, serial transfection of mRNAs encoding a therapeutically relevant chimeric antigen receptor (CAR) payload produced functional CAR T cells. These results demonstrate that LNPs can be a viable platform for serial and iterative T cell engineering using multiple mRNA payloads, providing an alternative to electroporation for the engineering of therapeutic T cells.

Overview

CoChat Summary

TL;DR

This study shows that DOTAP/DOPE-containing lipid nanoparticles (SM102-DD) can serially deliver mRNA to primary human T cells with higher viable cell yields than electroporation while producing functional uPAR CAR T cells. The platform preserves untransfected bystander cells across four rounds, though per-round transfection efficiency remains lower than electroporation.

Key findings

  • SM102-DD LNPs (5% DOTAP + 5% DOPE) delivered reporter mRNA more efficiently than SM102-DSPC; replacing DSPC with 5% DOTAP gave 50-fold more transfected cell yield, and adding DOPE augmented this by 1.8-fold.
  • Four serial transfections every 24 h maintained reporter expression and produced 100% higher live-cell yield than electroporation; LNP-treated cultures had significantly higher total viable cell number and more live untransfected cells across rounds.
  • Uptake was primarily via macropinocytosis: EIPA and MβCD reduced eGFP MFI to 1,370 and 1,710 vs 4,483 untreated (~3-fold lower), while clathrin, dynamin, and caveolae inhibitors did not significantly reduce transfected cell yield.
  • Serial uPAR CAR mRNA delivery produced functional CAR T cells: CAR surface MFI rose from 722 to 3,535 across 250–1,000 ng doses; target-cell killing was comparable to electroporation by 96 h, with higher CD69+CD25+ activation and IFN-γ vs mock, and exhaustion markers below 1.5%.

Methods

  • In vitro primary human CD3+ T cells from healthy donors (16 donors total; typical n = 9, 3 donors), activated 48 h and cultured in ImmunoCult-XF + 100 IU/mL IL-2.
  • LNPs formulated by vortex mixing with SM102, cholesterol, DMG-PEG2000, and DSPC/DOTAP/DOPE; characterized by DLS, RiboGreen, and zeta potential. Reporter mRNA (0.5 µg/500,000 cells) or uPAR CAR mRNA (2 µg/700,000 cells) was delivered every 24 h for four rounds and compared with Lonza 4D electroporation (EO115/CM138).
  • Readouts: flow cytometry for expression/viability/phenotype, confocal imaging for uptake/lysosomal colocalization, Incucyte cytotoxicity, IFN-γ ELISA, and ANOVA.

Limitations

  • Stated: LNP inflammatory responses were not evaluated; activation/exhaustion was assessed only at endpoint; longer-term persistence, memory differentiation, and functional durability need study; different mRNA doses/transcript lengths may affect viability/yield; donor variability requires larger diverse cohorts; assays did not fully distinguish electroporation-mediated death from CAR-dependent cytotoxicity.
  • Stated: per-round LNP efficiency was lower than electroporation during the first two transfections; CAR-dependent effects were more robustly resolved in the electroporation arm, and LNP treatment may elevate PD-1+TIM-3+ independent of CAR.
  • Evident: donors were not age- or sex-matched and donor number was not formally powered; LNPs were made by vortex mixing, which may yield larger/less uniform particles than microfluidic methods; data are available only upon request.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/j.omtn.2026.103081

Cites

107 of 107 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Image 1
CC BY-NC-ND · From the PDF
Figure 2 Adding DOPE to DOTAP-containing LNPs to make SM102-DD LNPs improve mRNA delivery to primary human T cells ex vivo
Figure 2 Adding DOPE to DOTAP-containing LNPs to make SM102-DD LNPs improve mRNA delivery to primary human T cells ex vivoCC BY-NC-ND · From the PDF
Image 3
CC BY-NC-ND · From the PDF
Figure 4 SM102-DD LNPs enter human T cells primarily via macropinocytosis
Figure 4 SM102-DD LNPs enter human T cells primarily via macropinocytosisCC BY-NC-ND · From the PDF
Figure 5 Serial mRNA transfection with SM102-DD LNPs generates fewer dead transfected T cells than serial electroporation
Figure 5 Serial mRNA transfection with SM102-DD LNPs generates fewer dead transfected T cells than serial electroporationCC BY-NC-ND · From the PDF
Figure 6 Serial mRNA transfection with SM102-DD LNPs produces high cell yields for both transfected and untransfected cells compared to electroporation
Figure 6 Serial mRNA transfection with SM102-DD LNPs produces high cell yields for both transfected and untransfected cells compared to electroporationCC BY-NC-ND · From the PDF
Image 7
CC BY-NC-ND · From the PDF
Figure 8 CAR T cells generated by SM102-DD LNP delivery are cytotoxic and exhibit antigen-specific activation with cytokine secretion
Figure 8 CAR T cells generated by SM102-DD LNP delivery are cytotoxic and exhibit antigen-specific activation with cytokine secretionCC BY-NC-ND · From the PDF

Verification

Claims the paper makes

0 Valid · 0 Not valid · 37 Not checked · 100 Own results and interpretations

59 more claims

Create a free account to see all 137 claims and to verify the 57 references still open.

See all claims — free account
  • It may state two separate claims as one. 46
  • Probably not a substantial claim. 31

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

4 of 4

Citations

Cites

Show all 107 references

Research works printed but not linked: 1

  1. Metzloff, 2024, Antigen presenting cell mimetic lipid nanoparticles for rapid mRNA CAR T cell cancer immunotherapy (adv. Mater. 26/2024), Adv. Mater., 36

Cited by

Still being checked.

Metadata

Authors
Ramamurthy, A., Scimonelli, G., Murphy, W. L., & Saha, K.
Affiliations
University of Wisconsin–Madison (US)
Corresponding author
  • Murphy, William L.
  • Saha, Krishanu
Venue
Molecular Therapy Nucleic Acids
Publisher
Elsevier BV
Published
2026-12
Volume
37
Issue
4
Pages
103081
ISSN
2162-2531 (ISSN-L)
OpenAlex
W7206213539
Cited by
0
References
104
FWCI
0.00
Type
journal article
Language
en
Open access
Licence
Locations
  • Molecular Therapy — Nucleic Acids (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • National Science Foundation (EEC 1648035)
  • National Institutes of Health (R01 CA278051, R35 GM119644)
  • Wisconsin Alumni Research Foundation
  • Office of the Vice Chancellor for Research and Graduate Education, University of Wisconsin-Madison
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Health Sciences › Medicine › Oncology › CAR-T cell therapy research
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords
T cell engineering, lipid nanoparticles, mRNA delivery, cationic lipids, chimeric antigen receptor T cells, chimeric antigen receptor, T cell viability, non-viral gene delivery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-21, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-21 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human T cell engineering via serial delivery of mRNA encapsulated within lipid nanoparticles. https://app.cochat.ai/papers/10.1016/j.omtn.2026.103081
The paper
Ramamurthy, A., Scimonelli, G., Murphy, W. L., & Saha, K. (2026). Human T cell engineering via serial delivery of mRNA encapsulated within lipid nanoparticles. Molecular Therapy Nucleic Acids. https://doi.org/10.1016/j.omtn.2026.103081

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.